Observes brentuximab vedotin use in adults with Hodgkin lymphoma after stem cell transplant
Studies how brentuximab vedotin is used in adults with Hodgkin lymphoma after stem cell transplant.
Plain-language title generated from the registry record
Registry title: A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
Key facts
- Where
- Gdansk, Katowice, Krakow, Lodz, Lublin, Olsztyn, Poznan, Tomaszow Mazowiecki, Warsaw, and Wroclaw, PolandSee the 13 sites
Where in Poland
- Uniwersyteckie Centrum Kliniczne, GdanskGdansk, PolandTaking people
- Samodzielny Publiczny Szpital Kliniczny im. Andrzeja Mieleckiego Slskiego Uniwersytetu Medycznego w KatowicachKatowice, PolandTaking people
- Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie- Panstwowy Instytut Badawczy Oddzial w KrakowieKrakow, PolandTaking people
- Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki w KrakowieKrakow, PolandTaking people
- Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w LodziLodz, PolandTaking people
- Centrum Onkologii Ziemi Lubelskiej im sw Jana z DukliLublin, PolandTaking people
- Samodzielny Publiczny Zaklad Opieki Zdrowotnej MSWiA z Warminsko - Mazurskim Centrum Onkologii w OlsztynieOlsztyn, PolandTaking people
- Szpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w PoznaniuPoznan, PolandTaking people
- NU-MED Specjalistyczny Szpital Onkologiczny Tomaszow MazowieckiTomaszow Mazowiecki, PolandTaking people
- Instytut Hematologii I TransfuzjologiiWarsaw, PolandTaking people
- Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut BadawczyWarsaw, PolandTaking people
- Uniwersyteckie Centrum Kliniczne WUMWarsaw, PolandTaking people
- Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we WroclawiuWroclaw, PolandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Takeda
- Trial code
- NCT05100056
- Record updated
- 27 May 2026
- Original description
The main aim is to check how effective BV is for treating adults with HL.Read full original descriptionShow less
Effectiveness and Safety of Consolidative Brentuximab Vedotin (BV) Treatment Administered to Hodgkin's Lymphoma (HL) Patients That Had Undergone Autologous Stem Cell Transplant (ASCT). Prospective, Multicenter, Observational Study
The main aim is to check how effective BV is for treating adults with HL.
Study medication will be prescribed according to the clinic's standard practice.
Participants will visit the study clinic 5 times, once every 12 weeks. When study treatment has completed, a follow-up visit will be scheduled every 3 months during the first year and every 4-6 months during the next year.
Inclusion: Adult participant (aged greater than or equal to [>=18] years) that underwent or are candidates for ASCT and were enrolled in BV HL NDP receiving treatment according to the Summary of Product Characteristics for Adcetris and NDP.
Exclusion: Currently participates or plans to participate in any interventional clinical trial; Any other reason that, in the Investigator's opinion, makes the participant unsuitable to participate in this study.